glp-1 discontinuation weight regain Many Patients Maintain Loss a Year After Stopping Semaglutide and Liraglutide Beyond GLP-1 Agonists: An Adaptive

Presented for research literature review only Benveniste R et al

The FDA has acknowledged this reality on the label itself: weight care requires ongoing therapy , and GLP-1 drugs are approved for chronic weight management only as an adjunct to diet and exercise they are not magic bullets that cure obesity after a few doses

Zepbound (weekly injection, weight management) Approved in 2023, the same molecule and doses labelled for weight management, with a later indication for moderate-to-severe obstructive sleep apnoea in adults with obesity

When combined, the peptides create a complementary rhythm, with CJC-1295 offering a steady release and Ipamorelin adding sharp pulses